Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
121714913 | 12171491 | 3 | F | 20160808 | 20160311 | 20160816 | EXP | US-JNJFOC-20160306953 | JANSSEN | REDDY A, YENNURAJALINGAM S, REDDY S, WU J, LIU D, DEV R, ET AL. THE OPIOID ROTATION RATIO FROM TRANSDERMAL FENTANYL TO ^STRONG^ OPIOIDS IN PATIENTS WITH CANCER PAIN. JOURNAL OF PAIN + SYMPTOM MANAGEMENT 2016;51(6):1040-5. REDDY AS, YENNU S, REDDY SK, WU J, LIU DD, BRUERA E, ET AL. THE OPIOID ROTATION RATIO (ORR) TO TRANSDERMAL FENTANYL (TDF) TO STRONG OPIOIDS IN CANCER PATIENTS. JOURNAL OF CLINICAL ONCOLOGY 2015 PALLIATIVE CARE IN ONCOLOGY SYMPOSIUM 2015;33 (29 SUPPL 1). | 0.00 | Y | 0.00000 | 20160816 | MD | US | US |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
121714913 | 12171491 | 1 | PS | FENTANYL. | FENTANYL | 1 | Transdermal | N | U | 19813 | UNSPECIFIED |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
121714913 | 12171491 | 1 | Cancer pain |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
121714913 | 12171491 | OT |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
121714913 | 12171491 | Nausea | |
121714913 | 12171491 | Neurotoxicity | |
121714913 | 12171491 | Pain |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
no results found |